Proteus Digital Health has received de novo FDA 510k clearance for its Ingestible Event Monitor medication adherence system after four year review.
Tag: CE Mark
Cellnovo’s Mobile Diabetes Management System gets approval from European regulators
Cellnovo received CE Mark approval for its mobile diabetes management system, which includes an insulin patch pump and a wireless, touch screen handset.
